Biotron Limited (BITRF)

USD 0.01

(0.0%)

Revenue Summary of Biotron Limited

  • Biotron Limited's latest annual revenue in 2024 was 1.64 Million AUD , up 14.94% from previous year.
  • Biotron Limited's latest quarterly revenue in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Biotron Limited reported a annual revenue of 1.43 Million AUD in annual revenue 2023, down -8.16% from previous year.
  • Biotron Limited reported a annual revenue of 1.55 Million AUD in annual revenue 2022, up 6.61% from previous year.
  • Biotron Limited reported a quarterly revenue of - AUD for 2024 Q4, down 0.0% from previous quarter.
  • Biotron Limited reported a quarterly revenue of - AUD for 2024 FY, down -100.0% from previous quarter.

Annual Revenue Chart of Biotron Limited (2024 - 2000)

Historical Annual Revenue of Biotron Limited (2024 - 2000)

Year Revenue Revenue Growth
2024 1.64 Million AUD 14.94%
2023 1.43 Million AUD -8.16%
2022 1.55 Million AUD 6.61%
2021 1.46 Million AUD 2823.89%
2020 50 Thousand AUD -95.34%
2019 1.07 Million AUD 115134.37%
2018 931.00 AUD -99.94%
2017 1.65 Million AUD 7.19%
2016 1.54 Million AUD -7.42%
2015 1.67 Million AUD -2.92%
2014 1.72 Million AUD 93.11%
2013 891.95 Thousand AUD 0.0%
2012 - AUD 0.0%
2011 - AUD 0.0%
2010 - AUD 0.0%
2009 - AUD 0.0%
2008 - AUD -100.0%
2007 402.45 Thousand AUD -49.37%
2006 794.86 Thousand AUD 0.0%
2005 - AUD 0.0%
2004 - AUD 0.0%
2003 - AUD -100.0%
2002 62.74 Thousand AUD 380.4%
2001 13.06 Thousand AUD 0.0%
2000 - AUD 0.0%

Peer Revenue Comparison of Biotron Limited

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 89.57%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -9236.099%
SQZ Biotechnologies Company 21.47 Million USD 92.34%
Evofem Biosciences, Inc. 18.21 Million USD 90.97%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 98.662%
Mesoblast Limited 5.9 Million USD 72.126%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.754%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -301.086%
Marizyme, Inc. 645.81 Thousand USD -154.737%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -2043.164%
Intellipharmaceutics International Inc. 65.72 Thousand USD -2402.912%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -4062.949%
MultiCell Technologies, Inc. 49.32 USD -3335492.052%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 96.691%
EV Biologics, Inc. 48.9 Thousand USD -3264.241%
Q BioMed Inc. 284.35 Thousand USD -478.548%
Emmaus Life Sciences, Inc. 29.59 Million USD 94.442%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.329%
Oncotelic Therapeutics, Inc. 70 Thousand USD -2250.163%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -1561.832%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -2072.513%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -149.827%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.989%
Halberd Corporation 999.00 USD -164576.076%
Enzolytics Inc. 52.79 Thousand USD -3015.982%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD -20.169%
SYBLEU INC 11.69 Thousand USD -13965.612%
Nuo Therapeutics, Inc. 608.52 Thousand USD -170.345%
argenx SE 1.22 Billion USD 99.866%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 14.849%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -166.465%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.804%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 98.866%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -194.977%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -64.886%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 96.598%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 90.14%
ONE Bio Corp. 52.29 Million USD 96.854%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -595.432%
Regen BioPharma, Inc. 236.56 Thousand USD -595.432%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -1073.054%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -247.268%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 78.879%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -12554.723%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -4061.264%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 50.597%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 75.317%
IntelGenx Technologies Corp. 1.03 Million USD -58.336%
Gelesis Holdings, Inc. 25.76 Million USD 93.615%
CSL Limited 14.8 Billion USD 99.989%
Cellectis S.A. 755 Thousand USD -117.896%